Editorial · 30 Jan 2025
CommentaryPublished 29 Jul 2023
Current and Emerging Pharmacological Dementia Treatment Options
Department of Bioinformatics and Molecular Genetics and Center for Biological Systems Analysis, Netherlands
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Dementia is a progressive neurodegenerative disorder that affects millions of people worldwide, causing cognitive decline, memory loss, and behavioral changes. While there is no cure for dementia, pharmacological treatments aim to manage symptoms and slow down disease progression. This article provides an overview of the current pharmacological options, including cholinesterase inhibitors and NMDA receptor antagonists, commonly used in dementia treatment. Additionally, it explores emerging therapies, such as anti-amyloid therapies, tau protein stabilizers, anti-inflammatory drugs, and neuroprotective agents, which hold promise for modifying the underlying pathology of dementia. Continued research in pharmacological interventions is crucial for developing more effective treatments and improving the lives of individuals affected by dementia.
Keywords
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Dementia.
Editorial · 30 Jan 2025
Advances in Early Dementia Diagnosis: The Role of Imaging and Genetic Markers
Perspective · 30 Jan 2025
The Impact of Aging on Cognitive Function: Exploring Molecular Pathways and Interventions
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Dementia
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Roest Simons”
